openPR Logo
Press release

Creative Peptides Released GMP Synthesis Service

09-04-2018 10:06 AM CET | Health & Medicine

Press release from: Creative Peptides

Located in Shirley, New York, the world’s leading peptide supplier Creative Peptides announced the launch of its GMP synthesis (https://www.creative-peptides.com/services/custom-gmp-peptide-synthesis-services.html ) business on August 29, 2018. Now this company is focused on the development and GMP manufacturing of pharmaceutical grade peptides.
As the demand of pharmaceutical market continues to grow, more and more pharmas and research institutions choose the CMO and CRO models to expand their businesses, which is more cost-saving, efficient without additional expenses on staff, equipment and other infrastructure. Creative Peptides has become the first choice to outsource the manufacturing of peptides or active pharmaceutical ingredients (APIs) in any quantities, owing to its world-in-class technologies, strong technical staff and strict quality control systems.
“We are able to produce GMP peptides, APIs in annual quantities as needed by our customers. The availability of low-cost active pharmaceutical ingredients from our company has had a big impact in the international community,” said Dr. Robert Martinez, Head of Creative Peptides’ synthesis businesses, in a statement. “Our robust, economical manufacturing processes will definitely help optimize the costs of drug discovery and development. A full range of synthetic technologies are available. But as to which technology to be used, the final choice depends on the sequence length, the scale, and the specific project requirements.”
The GMP synthesis range at Creative Peptides includes:
Large-Scale Liquid (Solution) Phase Peptide Synthesis (LPPS)
Large-Scale Solid Phase Peptide Synthesis (SPPS)
Large-Scale Hybrid Fragment Synthesis Peptide
Modifications
Large-Scale Purification
Large-Scale Isolation
Whenever and wherever, quality control is the top priority for Creative Peptides. The GMP production sites were designed in strict accordance to US-FDA guidelines. All have passed US-FDA inspections. Currently this company is qualified for the manufacturing of generic APIs in compliance with ICH guidelines including Q7 and other related and applicable sections.
>98% purity of the GMP synthetic products is guaranteed. Standard QC tests before releasing GMP products are also provided. Extra tests can be made as well according to the requests of clients.

About Creative Peptides
With a high profile team of experts in multiple fields such as peptide technology and synthetic chemistry, Creative Peptides not only provides various research peptides, like anti-pigmentation peptide (https://www.creative-peptides.com/product/anti-pigmentation-54.html), neoantigen (https://www.creative-peptides.com/services/neoantigen-peptides-vaccine-synthesis-service.html), glucagon like peptides, but also dedicates to solving the problems that trouble its clients by offering various GMP synthesis services.

Creative Peptides

45-16 Ramsey Road, Shirley, NY 11967, USA

Caroline Miller

contact@creative-peptides.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Creative Peptides Released GMP Synthesis Service here

News-ID: 1217565 • Views: 238

More Releases for Peptide

Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established
Peptide Therapeutics Market | Forecast up to 2024
Global Peptide Therapeutics Market: Overview This report provides in-depth region wise and country wise analysis of the peptide therapeutics market. Stakeholders of this report include manufacturers of peptide products, raw material suppliers, nutraceutical and cosmeceutical companies, food processing industries and new players planning to enter the market. It further provides qualitative and quantitative analysis of the global peptide therapeutics market. Qualitative analysis comprises market dynamics, trends, product overview, and country-level market
Peptide Vaccine Market Peptide Vaccine Clinical Pipeline Report 2020
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Peptide Vaccine: A Prologue to Sub-Unit Vaccines 1.1 Introduction 1.2 Glimpse of Antiquity 2. Need of Peptide Vaccines 2.1 Why Peptides – More Desirable 2.2 Peptide Vaccines V/S Traditional Vaccines 3. Classification of Peptide Vaccines 3.1 On the Basis of Sources Obtained 3.2 On the Basis of Length 3.3 On the Basis of
Global Natriuretic Peptide Market Research Report 2017
Report Hive Market Research Released a New Research Report of 107 pages on Title " Global Natriuretic Peptide Market Research Report 2017 "with detailed Analysis, Forecast and Strategies. In this report, the global Natriuretic Peptide market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented
Global Peptide Therapeutics Pipeline Insight 2015
Peptides are small molecules of varying molecular masses that consist of amino acids joined with the help of peptide bonds (CONH2). One end of the molecule consists of carboxyl (COOH2) group while the other end has amino (NH2) group giving rise to polarity. Biologically, they are very important and found to play an important role in various anabolic and catabolic processes. They are essential component of cell signaling pathways, immune
Global Peptide Vaccine Market & Pipeline Insight
Peptide vaccines are peptides that exhibit pharmacological properties by activating human immune system rather than showing pharmacologically activity by themselves. They are administered into body to enter in lymph nodes where they induce long lasting immune response. They utilize immune system and develop long term acquired immunity which has capability to prevent future incidences of pathogen attack. Every living cell in human body has surface markers as an instrument to